Alland & Robert marks 141 years with innovation-driven expansion into Asia and the Middle East

Published: 22-Oct-2025
Ingredients

At Gulfood Manufacturing 2025, Alland & Robert will showcase its latest sustainable gum solutions — Syndeo Gelling and Beyond Acacia — as the company reinforces its global leadership and launches new R&D consulting services for food and cosmetic manufacturers

This year, Alland & Robert is celebrating 141 years of expertise and is looking to strengthen its international presence with a clear focus on innovation and sustainability.

As a global leader and pioneer of natural gums, Alland & Robert is expanding into Asia and the Middle East, aiming to build new partnerships and support local manufacturers in developing healthier, more sustainable food solutions.

The company will showcase its achievements at Gulfood Manufacturing in Dubai on November 4-6, at booth #R-H50.

Visitors to the show can see Alland & Robert's innovations, including the following:

  • A&R Services: Alland & Robert provides R&D support to help agri-food and cosmetic companies design and scale acacia gum-based products that meet current market needs
  • Syndeo Gelling: a vegan texture agent, based on acacia gum, to substitute gelatin or other gelling agents
  • Beyond Acacia: thanks to an innovative transformation process, Beyond Acacia offers high solubility and ease of use
    • Its new granulometry improves hydration, optimises cold solubilisation and enhances dispersion efficiency while reducing foam, dust and lump formation.
See more

You may also like

Ingredients

De-risk early stage drug development with Lonza Advanced Synthesis

Read more
Located at stand 5.1B76, Lonza is set to shed light on the issues facing drug developers and how AI-assisted tools improve the process

Trending Articles

  1. Roquette launches KLEPTOSE Crysmeb methyl-beta-cyclodextrin for oral and parenteral formulations The addition of the novel pharmaceutical excipient boosts the company's already extensive cyclodextrins portfolio
  2. Almac Group The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
  4. De-risk early stage drug development with Lonza Advanced Synthesis Located at stand 5.1B76, Lonza is set to shed light on the issues facing drug developers and how AI-assisted tools improve the process
  5. Piramal Pharma Solutions Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our clients through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs and finished dosage forms. We also offer specialized services such as development and manufacture of highly potent APIs, antibody drug conjugation, sterile fill/finish with and without containment, and potent solid oral drug product. Our capability as an integrated service provider & experience with various technologies enables us to serve innovator and generic companies worldwide.

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Ingredients

De-risk early stage drug development with Lonza Advanced Synthesis

Located at stand 5.1B76, Lonza is set to shed light on the issues facing drug developers and how AI-assisted tools improve the process
Ingredients

Roquette launches KLEPTOSE Crysmeb methyl-beta-cyclodextrin for oral and parenteral formulations

The addition of the novel pharmaceutical excipient boosts the company's already extensive cyclodextrins portfolio
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals

People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Ingredients

CPHI 2025: BENEO to present galenIQ as the granulation binder of choice

At this year’s CPHI Europe in Frankfurt (28–30 October), BENEO will showcase the latest advancements in granulation with its pharmaceutical-grade isomalt excipient: galenIQ
Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
Ingredients

Debunking the myths of HPMC adoption

Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
Subscribe now